TY - JOUR
T1 - Are your kidneys ok? Detect early to protect kidney health
AU - Vassalotti, Joseph A.
AU - Francis, Anna
AU - Soares Dos Santos, Augusto Cesar
AU - Correa-Rotter, Ricardo
AU - Abdellatif, Dina
AU - Hsiao, Li Li
AU - Roumeliotis, Stefanos
AU - Haris, Agnes
AU - Kumaraswami, Latha A.
AU - Lui, Siu Fai
AU - Balducci, Alessandro
AU - Liakopoulos, Vassilios
N1 - Publisher Copyright:
© 2025 Sociedad Española de Nefrología
PY - 2025/8/1
Y1 - 2025/8/1
N2 - Early identification of kidney disease can protect kidney health, prevent kidney disease progression and related complications, reduce cardiovascular disease risk and decrease mortality. We must ask “Are your kidneys ok?” using serum creatinine to estimate kidney function and urine albumin to assess for kidney and endothelial damage. Evaluation for causes and risk factors for chronic kidney disease (CKD) includes testing for diabetes and measurement of blood pressure and body mass index. This World Kidney Day we assert that case finding in high-risk populations, or even population level screening, can decrease the burden of kidney disease globally. Early-stage CKD is asymptomatic, simple to test for and recent paradigm shifting CKD treatments such as sodium glucose co-transporter-2 inhibitors dramatically improve outcomes and favor the cost-benefit analysis for screening or case-finding programs. Despite this, numerous barriers exist, including resource allocation, healthcare funding, healthcare infrastructure and healthcare-professional and population awareness of kidney disease. Coordinated efforts by major kidney non-governmental organizations to prioritise the kidney health agenda for governments and aligning early detection efforts with other current programs will maximise efficiencies.
AB - Early identification of kidney disease can protect kidney health, prevent kidney disease progression and related complications, reduce cardiovascular disease risk and decrease mortality. We must ask “Are your kidneys ok?” using serum creatinine to estimate kidney function and urine albumin to assess for kidney and endothelial damage. Evaluation for causes and risk factors for chronic kidney disease (CKD) includes testing for diabetes and measurement of blood pressure and body mass index. This World Kidney Day we assert that case finding in high-risk populations, or even population level screening, can decrease the burden of kidney disease globally. Early-stage CKD is asymptomatic, simple to test for and recent paradigm shifting CKD treatments such as sodium glucose co-transporter-2 inhibitors dramatically improve outcomes and favor the cost-benefit analysis for screening or case-finding programs. Despite this, numerous barriers exist, including resource allocation, healthcare funding, healthcare infrastructure and healthcare-professional and population awareness of kidney disease. Coordinated efforts by major kidney non-governmental organizations to prioritise the kidney health agenda for governments and aligning early detection efforts with other current programs will maximise efficiencies.
KW - Albuminuria
KW - Case finding
KW - Chronic kidney disease
KW - Prevention
KW - Proteinuria
KW - Screening
UR - https://www.scopus.com/pages/publications/105020982316
U2 - 10.1016/j.nefroe.2025.501344
DO - 10.1016/j.nefroe.2025.501344
M3 - Article
AN - SCOPUS:105020982316
SN - 0211-6995
VL - 45
JO - Nefrologia
JF - Nefrologia
IS - 7
M1 - 501344
ER -